Kymera Therapeutics (KYMR) traded down -0.08 % during a 24 hours period ending at 04:56 PM Central Europe on Monday 26th. One Kymera Therapeutics stock can currently be bought for about USD 112.99 on popular exchanges. Current supply of Kymera Therapeutics stocks is 83.2 mn. Kymera Therapeutics has a current market capitalization of USD 9.2 bn and approximately USD 57.3 mn worth of Kymera Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Kymera Therapeutics has traded -4.36 % down. Simple moving average of last 200 days is at USD 95.26. The highest price of past 52 weeks was recorded at USD 130.05 on 06/25/2026. 52 weeks low was at USD 55.66 on 11/04/2025.
Here is how related stocks have performed in the past 24 hours:
Generac (GNRC) traded down -0.59 % and now trades at USD 190.89. Generac has a market capitalisation of USD 11 bn. Current price/earnings ratio for Generac is 43.48.
Globus Medical (GMED) traded down -0.31 % and now trades at USD 81.13. Current market capitalisation for Globus Medical is USD 10.9 bn. Globus Medical has a current price to earnings ratio of 20.83.
Universal Health Services (UHS) traded down -0.66 % and now trades at USD 186.71. Current market capitalisation for Universal Health Services is USD 11 bn. Current price/earnings ratio for Universal Health Services is 7.63.
Molina Healthcare (MOH) traded down -3.46 % and now trades at USD 206.11. Molina Healthcare has a market capitalisation of USD 10.9 bn.
Align (ALGN) traded down -0.64 % and now trades at USD 152.47. Current market capitalisation for Align is USD 11 bn. Align has a current price to earnings ratio of 26.83.
About Kymera Therapeutics
Kymera Therapeutics, Inc. is a biopharmaceutical company that specializes in discovering and developing novel small molecule therapeutics. These therapeutics selectively degrade disease-causing proteins by utilizing the body’s natural protein degradation system. The company operates in the health care sector and has its main operations in Watertown, United States. Their web address is www.kymeratx.com , and they are listed on the Nasdaq stock exchange.


